Showing results (31-40 of 154) with videos related to
Sort By:
Pageof 16
Journal of Alzheimer'S Disease : JAD|July 22, 2017
Computerized Cognitive Screen (CoCoSc): A Self-Administered Computerized Test for Screening for Cognitive Impairment in Community Social CentersAdrian Wong, Ching-Hang Fong, Vincent Chung-Tong Mok, et al.Clinical and Translational Medicine|October 9, 2018
Combination systemic therapies with immune checkpoint inhibitors in pancreatic cancer: overcoming resistance to single-agent checkpoint blockadeJun Gong, Andrew Hendifar, Richard Tuli, et al.Cancer|June 22, 2011
Adjuvant chemotherapy improves survival in patients with American Joint Committee on Cancer stage II colon cancerShaun McKenzie, Rebecca Nelson, Brian Mailey, et al.Clinical Journal of Oncology Nursing|July 25, 2017
Palliative Care and Phase 1 Trials: Intervention to Improve Quality of Life and Provide EducationBetty R Ferrell, Vincent Chung, Marianna Koczywas, et al.Movement Disorders : Official Journal of the Movement Disorder Society|July 11, 2006
Efficacy and safety of herbal medicines for idiopathic Parkinson's disease: a systematic reviewVincent Chung, Liang Liu, Zhaoxiang Bian, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|December 18, 2008
Treatment response to transcatheter arterial embolization and chemoembolization in primary and metastatic tumors of the liverAvo Artinyan, Rebecca Nelson, Perry Soriano, et al.Chinese Journal of Integrative Medicine|July 24, 2012
Emotionless holism: factor and Rasch analysis of the Chinese Integrative Medicine Attitude QuestionnaireVincent Chung, Marc Chong, Lau Chun Hong, et al.JAMA Network Open|May 14, 2020
Model of a Queuing Approach for Patient Accrual in Phase 1 Oncology StudiesPaul H Frankel, Vincent Chung, Joseph Tuscano, et al.Trials|November 4, 2017
The effects of yoga versus stretching and resistance training exercises on psychological distress for people with mild-to-moderate Parkinson's disease: study prxotocol for a randomized controlled trialJoJo Yan Yan Kwok, Jackie Cheuk Yin Kwan, Man Auyeung, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 2017
Safety, Tolerability, and Preliminary Activity of LB-100, an Inhibitor of Protein Phosphatase 2A, in Patients with Relapsed Solid Tumors: An Open-Label, Dose Escalation, First-in-Human, Phase I TrialVincent Chung, Aaron S Mansfield, Fadi Braiteh, et al.Pageof 16